Clinical Trials Logo

Filter by:
NCT ID: NCT00282503 Terminated - Clinical trials for Acute Graft-versus-Host Disease

Extracorporeal Photoimmune Therapy With UVADEX for the Treatment of Acute Graft Versus-Host Disease

Start date: January 2006
Phase: Phase 3
Study type: Interventional

The purpose of this study is to compare the safety and efficacy of ECP treatment combined with high dose corticosteroids versus high dose corticosteroids alone, in the treatment of patients with newly diagnosed acute GvHD (Grades II to III) that developed within 100 days following an allo HPCT.

NCT ID: NCT00281099 Terminated - Heart Disease Clinical Trials

Managed Ventricular Pacing ("MVP") Trial

MVP
Start date: October 2004
Phase: N/A
Study type: Interventional

The purpose of the study is to compare two device settings (sets of instructions) used by the ICD. The Implantable Cardiac Defibrillator ("ICD") can be set to use one wire (top or bottom of the heart) or two wires (top and bottom). The study will compare how much time either ICD wire is used by the ICD and the status of congestive heart failure.

NCT ID: NCT00280800 Completed - Clinical trials for Sleep Apnea, Obstructive

Effectiveness of Auto-adjusted Continuous Positive Airway Pressure for Long-term Treatment of Sleep Apnea

Start date: January 2006
Phase: N/A
Study type: Interventional

Hypothesis: Computer controlled continuous positive airway pressure (autoCPAP) is equally effective in improving obstructive sleep apnea syndrome symptoms, breathing disturbances, objective vigilance, and it is cost-effective compared to conventional fixed continuous positive airway pressure.

NCT ID: NCT00279760 Completed - Clinical trials for Rheumatoid Arthritis

Phase I/II Multiple-Dose LEA29Y vs CTLAG4Ig vs Placebo in Rheumatoid Arthritis

Start date: n/a
Phase: Phase 1/Phase 2
Study type: Interventional

This randomized, double-blind, placebo controlled, parallel and multiple dose study provided safety, preliminary efficacy, and immunogenicity information about the use of BMS-188667 and BMS-224818 in subjects with RA

NCT ID: NCT00279175 Completed - Clinical trials for Myocardial Infarction

REPAIR-AMI: Intracoronary Progenitor Cells in Acute Myocardial Infarction (AMI)

Start date: April 2004
Phase: Phase 3
Study type: Interventional

Impaired contractile function after a heart attack of the heart is a major cause of "heart failure" limiting quality of life and prognosis, which cannot be prevented even with optimal standard therapy, including immediate balloon/stent dilation of the infarct vessel. The aim of the REPAIR-AMI trial is to investigate whether infusion of progenitor cells into the infarct vessel (after successful reperfusion therapy) may improve left ventricular contractile function compared to placebo therapy. After bone marrow aspiration progenitor cells are enriched via a centrifugation method.

NCT ID: NCT00276640 Completed - Clinical trials for Primary Central Nervous System Neoplasms

Radiation Therapy or Combination Chemotherapy in Treating Patients With Clinically or Radiologically Progressive Low-Grade Gliomas

SIOP-LGG-2004
Start date: April 1, 2004
Phase: N/A
Study type: Interventional

RATIONALE: Radiation therapy uses high-energy x-rays to kill tumor cells. Drugs used in chemotherapy, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. PURPOSE: This clinical trial is studying giving radiation therapy or combination chemotherapy to see how well it works in treating patients with clinically or radiologically progressive low-grade gliomas.

NCT ID: NCT00275821 Completed - Clinical trials for Age Related Macular Degeneration

Efficacy and Safety of Ranibizumab in Patients With Subfoveal Choroidal Neovascularization (CNV) Secondary to Age-related Macular Degeneration (AMD)

EXCITE
Start date: December 2005
Phase: Phase 3
Study type: Interventional

The study will test if the efficacy and safety of an alternative dosing regimen is as effective as monthly injections.

NCT ID: NCT00275210 Completed - Colonic Neoplasms Clinical Trials

MOSAIC - Multicenter International Study of Oxaliplatin/ 5FU-LV in the Adjuvant Treatment of Colon Cancer

Start date: October 1998
Phase: Phase 3
Study type: Interventional

To evaluate the FOLFOX regimen versus LV5FU2 in the adjuvant treatment of stage II and III colon cancer. Primary objective: Disease Free Survival (DFS) Secondary objective: Overall Survival (OS), safety (including long term toxicity)

NCT ID: NCT00274703 Completed - Clinical trials for Oesophagitis, Eosinophilic

An Evaluation Of Mepolizumab In Therapy Of Eosinophilic Oesophagitis In Adult Patients

Start date: December 2005
Phase: Phase 2
Study type: Interventional

Eosinophils play a key role in the pathogenesis of eosinophilic oesophagitis. Therapies that suppress eosinophil recruitment and activation may give a benefit. Mepolizumab is a humanised monoclonal antibody against interleukin-5 (IL-5). This study will evaluate the ability of mepolizumab to decrease the recruitment and infiltration of eosinophils into the oesophagus, thereby reducing the inflammation and symptoms of EE (eosinophilic oesophagitis) in adult patients.

NCT ID: NCT00274612 Completed - Hypertension Clinical Trials

Prospective Randomised Investigation of the Safety and Efficacy of Micardis® vs Ramipril Using ABPM

PRISMA
Start date: October 2002
Phase: Phase 4
Study type: Interventional

The primary objective of this study is to demonstrate that telmisartan 80 mg (MICARDIS®) is at least as effective and possibly superior to ramipril 5mg and 10mg in lowering mean ambulatory diastolic blood pressure (DBP) and systolic blood pressure (SBP) during the last 6 hours of the 24-hour dosing interval in mild-to-moderate hypertensive patients at the end of an 8 and 14-week treatment period, respectively.